The global market for Cevimeline was valued at US$ 128 million in the year 2024 and is projected to reach a revised size of US$ 175 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Cevimeline is used to treat the symptoms of dry mouth in patients with Sjogren's syndrome (a condition that affects the immune system and causes dryness of certain parts of the body such as the eyes and mouth). Cevimeline is in a class of medications called cholinergic agonists. It works by increasing the amount of saliva in the mouth.
The global Cevimeline market is experiencing moderate growth, primarily driven by the increasing prevalence of Sj枚gren's syndrome and other autoimmune disorders that lead to dry mouth (xerostomia). Cevimeline, a muscarinic receptor agonist, is primarily used to stimulate saliva production, providing relief to patients suffering from chronic dry mouth conditions. With growing awareness of Sj枚gren's syndrome and advancements in diagnostic capabilities, more patients are being identified and seeking treatment, which drives market demand. North America dominates the market due to higher diagnosis rates, advanced healthcare infrastructure, and the presence of major pharmaceutical companies. Europe also holds a significant share, while the Asia-Pacific region shows promising growth potential due to improving healthcare facilities, increasing healthcare awareness, and a rising patient population. However, the market faces challenges such as potential side effects of Cevimeline, including excessive sweating, nausea, and blurred vision, which may limit its use among certain patient groups. Additionally, the emergence of alternative therapies and natural treatments may pose a threat to market expansion. Key players are focusing on expanding their product portfolios, obtaining regulatory approvals, and investing in clinical research to explore broader indications for Cevimeline. Collaborations and partnerships for research and distribution are also observed to strengthen market positioning. As healthcare awareness increases and diagnostic technologies advance, the Cevimeline market is expected to grow steadily, though the development of more effective and safer treatment options may influence its long-term trajectory.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cevimeline, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cevimeline.
The Cevimeline market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cevimeline market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cevimeline manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Daiichi Sankyo
Lupin
Aurobindo Pharma
Rubicon Research
Cosette Pharmaceuticals
Hikma Pharmaceuticals
Bionpharma Inc
Rising Pharma Holdings, Inc.
Macleods Pharmaceuticals Limited
Bryant Ranch Prepack
Segment by Type
NDA
ANDA
Segment by Application
Hospitals
Clinics
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cevimeline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cevimeline in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Cevimeline Market Overview
1.1 Product Definition
1.2 Cevimeline by Type
1.2.1 Global Cevimeline Market Value Comparison by Type (2024 VS 2031)
1.2.2 NDA
1.2.3 ANDA
1.3 Cevimeline by Application
1.3.1 Global Cevimeline Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Cevimeline Market Size Estimates and Forecasts
1.4.1 Global Cevimeline Revenue 2020-2031
1.4.2 Global Cevimeline Sales 2020-2031
1.4.3 Global Cevimeline Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cevimeline Market Competition by Manufacturers
2.1 Global Cevimeline Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cevimeline Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cevimeline Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cevimeline, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cevimeline, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cevimeline, Product Type & Application
2.7 Global Key Manufacturers of Cevimeline, Date of Enter into This Industry
2.8 Global Cevimeline Market Competitive Situation and Trends
2.8.1 Global Cevimeline Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cevimeline Players Market Share by Revenue
2.8.3 Global Cevimeline Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cevimeline Market Scenario by Region
3.1 Global Cevimeline Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cevimeline Sales by Region: 2020-2031
3.2.1 Global Cevimeline Sales by Region: 2020-2025
3.2.2 Global Cevimeline Sales by Region: 2026-2031
3.3 Global Cevimeline Revenue by Region: 2020-2031
3.3.1 Global Cevimeline Revenue by Region: 2020-2025
3.3.2 Global Cevimeline Revenue by Region: 2026-2031
3.4 North America Cevimeline Market Facts & Figures by Country
3.4.1 North America Cevimeline Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cevimeline Sales by Country (2020-2031)
3.4.3 North America Cevimeline Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cevimeline Market Facts & Figures by Country
3.5.1 Europe Cevimeline Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cevimeline Sales by Country (2020-2031)
3.5.3 Europe Cevimeline Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cevimeline Market Facts & Figures by Region
3.6.1 Asia Pacific Cevimeline Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cevimeline Sales by Region (2020-2031)
3.6.3 Asia Pacific Cevimeline Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cevimeline Market Facts & Figures by Country
3.7.1 Latin America Cevimeline Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cevimeline Sales by Country (2020-2031)
3.7.3 Latin America Cevimeline Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cevimeline Market Facts & Figures by Country
3.8.1 Middle East and Africa Cevimeline Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cevimeline Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cevimeline Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cevimeline Sales by Type (2020-2031)
4.1.1 Global Cevimeline Sales by Type (2020-2025)
4.1.2 Global Cevimeline Sales by Type (2026-2031)
4.1.3 Global Cevimeline Sales Market Share by Type (2020-2031)
4.2 Global Cevimeline Revenue by Type (2020-2031)
4.2.1 Global Cevimeline Revenue by Type (2020-2025)
4.2.2 Global Cevimeline Revenue by Type (2026-2031)
4.2.3 Global Cevimeline Revenue Market Share by Type (2020-2031)
4.3 Global Cevimeline Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cevimeline Sales by Application (2020-2031)
5.1.1 Global Cevimeline Sales by Application (2020-2025)
5.1.2 Global Cevimeline Sales by Application (2026-2031)
5.1.3 Global Cevimeline Sales Market Share by Application (2020-2031)
5.2 Global Cevimeline Revenue by Application (2020-2031)
5.2.1 Global Cevimeline Revenue by Application (2020-2025)
5.2.2 Global Cevimeline Revenue by Application (2026-2031)
5.2.3 Global Cevimeline Revenue Market Share by Application (2020-2031)
5.3 Global Cevimeline Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Daiichi Sankyo Cevimeline Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Lupin
6.2.1 Lupin Company Information
6.2.2 Lupin Description and Business Overview
6.2.3 Lupin Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lupin Cevimeline Product Portfolio
6.2.5 Lupin Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Company Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aurobindo Pharma Cevimeline Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Rubicon Research
6.4.1 Rubicon Research Company Information
6.4.2 Rubicon Research Description and Business Overview
6.4.3 Rubicon Research Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Rubicon Research Cevimeline Product Portfolio
6.4.5 Rubicon Research Recent Developments/Updates
6.5 Cosette Pharmaceuticals
6.5.1 Cosette Pharmaceuticals Company Information
6.5.2 Cosette Pharmaceuticals Description and Business Overview
6.5.3 Cosette Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cosette Pharmaceuticals Cevimeline Product Portfolio
6.5.5 Cosette Pharmaceuticals Recent Developments/Updates
6.6 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Company Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hikma Pharmaceuticals Cevimeline Product Portfolio
6.6.5 Hikma Pharmaceuticals Recent Developments/Updates
6.7 Bionpharma Inc
6.7.1 Bionpharma Inc Company Information
6.7.2 Bionpharma Inc Description and Business Overview
6.7.3 Bionpharma Inc Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bionpharma Inc Cevimeline Product Portfolio
6.7.5 Bionpharma Inc Recent Developments/Updates
6.8 Rising Pharma Holdings, Inc.
6.8.1 Rising Pharma Holdings, Inc. Company Information
6.8.2 Rising Pharma Holdings, Inc. Description and Business Overview
6.8.3 Rising Pharma Holdings, Inc. Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rising Pharma Holdings, Inc. Cevimeline Product Portfolio
6.8.5 Rising Pharma Holdings, Inc. Recent Developments/Updates
6.9 Macleods Pharmaceuticals Limited
6.9.1 Macleods Pharmaceuticals Limited Company Information
6.9.2 Macleods Pharmaceuticals Limited Description and Business Overview
6.9.3 Macleods Pharmaceuticals Limited Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Macleods Pharmaceuticals Limited Cevimeline Product Portfolio
6.9.5 Macleods Pharmaceuticals Limited Recent Developments/Updates
6.10 Bryant Ranch Prepack
6.10.1 Bryant Ranch Prepack Company Information
6.10.2 Bryant Ranch Prepack Description and Business Overview
6.10.3 Bryant Ranch Prepack Cevimeline Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bryant Ranch Prepack Cevimeline Product Portfolio
6.10.5 Bryant Ranch Prepack Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cevimeline Industry Chain Analysis
7.2 Cevimeline Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cevimeline Production Mode & Process Analysis
7.4 Cevimeline Sales and Marketing
7.4.1 Cevimeline Sales Channels
7.4.2 Cevimeline Distributors
7.5 Cevimeline Customer Analysis
8 Cevimeline Market Dynamics
8.1 Cevimeline Industry Trends
8.2 Cevimeline Market Drivers
8.3 Cevimeline Market Challenges
8.4 Cevimeline Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Daiichi Sankyo
Lupin
Aurobindo Pharma
Rubicon Research
Cosette Pharmaceuticals
Hikma Pharmaceuticals
Bionpharma Inc
Rising Pharma Holdings, Inc.
Macleods Pharmaceuticals Limited
Bryant Ranch Prepack
听
听
*If Applicable.